PLUS THERAPEUTICS, INC. — Director's Dealing 2014

Apr 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-04-11

Reporting Person: Saad Mark E (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-11	Employee Stock Option	$2.38	A	170000	Acquired	2024-04-11	Common Stock (170000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Restricted Stock (Common Stock)	138430	Direct

Footnotes

F1: The Employee Stock Options vest 1/48th each month from date of grant.